Literature DB >> 4423599

Clearance and biologic half-life as indices of intrinsic hepatic metabolism.

D Perrier, M Gibaldi.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4423599

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  33 in total

1.  Pharmacokinetics in man of the N-acetylated metabolite of procainamide.

Authors:  J M Strong; J S Dutcher; W K Lee; A J Atkinson
Journal:  J Pharmacokinet Biopharm       Date:  1975-08

2.  Development of a Physiologically Based Pharmacokinetic Model for Sinogliatin, a First-in-Class Glucokinase Activator, by Integrating Allometric Scaling, In Vitro to In Vivo Exploration and Steady-State Concentration-Mean Residence Time Methods: Mechanistic Understanding of its Pharmacokinetics.

Authors:  Ling Song; Yi Zhang; Ji Jiang; Shuang Ren; Li Chen; Dongyang Liu; Xijing Chen; Pei Hu
Journal:  Clin Pharmacokinet       Date:  2018-10       Impact factor: 6.447

3.  Importance of "first-pass elimination" for interindividual differences in steady-state concentrations of the adrenergic beta-receptor antagonist alprenolol.

Authors:  G Alván; M Lind; B Mellström; C von Bahr
Journal:  J Pharmacokinet Biopharm       Date:  1977-06

4.  Disposition of synethetic glucocorticoids. I. Pharmacokinetics of dexamethasone in healthy adults.

Authors:  S E Tsuei; R G Moore; J J Ashley; W G McBride
Journal:  J Pharmacokinet Biopharm       Date:  1979-06

Review 5.  Protein binding and kinetics of drugs in liver diseases.

Authors:  T F Blaschke
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

6.  The pharmacokinetics and metabolism of the anilide local anaesthetics in neonates. I. Lignocaine.

Authors:  G W Mihaly; R G Moore; J Thomas; E J Triggs; D Thomas; C A Shanks
Journal:  Eur J Clin Pharmacol       Date:  1978-05-17       Impact factor: 2.953

7.  Disposition of sodium valproate in epileptic patients.

Authors:  E Perucca; G Gatti; G M Frigo; A Crema; S Calzetti; D Visintini
Journal:  Br J Clin Pharmacol       Date:  1978-06       Impact factor: 4.335

8.  PD 141955 and CI-972: 9-deazaguanine analog purine nucleoside phosphorylase inhibitors. II. Effects on nucleoside catabolism in human and rat blood in vitro.

Authors:  M K Dong; R B Gilbertsen
Journal:  Agents Actions       Date:  1993

9.  Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent.

Authors:  U Klotz; P Müller-Seydlitz; P Heimburg
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

10.  Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs.

Authors:  E Perucca; A Richens
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.